Evidence map›Paper›PMID 18726168›Full record

ArticleFamilial cancer2009

Recurring MLH1 deleterious mutations in unrelated Chinese Lynch syndrome families in Singapore.

Hui-Ling Yap, Wei-Shieng Chieng, Jasmine Rui-Chen Lim, Robert Seng-Cheong Lim, Ross Soo, Jiayi Guo, Soo-Chin Lee

Abstract read
PubMed Publisher
In one paragraph

Article in Familial cancer, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Hui-Ling YapDepartment of Haematology-Oncology, National University Hospital, Singapore.
Wei-Shieng Chieng
Jasmine Rui-Chen Lim
Robert Seng-Cheong Lim
Ross Soo
Jiayi Guo
Soo-Chin Lee
National University Hospital · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lynch syndrome is an autosomal dominant disorder due to mutations in DNA mismatch repair genes, causing young onset colorectal cancer and extra-colonic cancers such as endometrial and stomach cancers. We genotyped MLH1 and MSH2 in patients suspected to have Lynch syndrome and correlated patient clinical characteristics and family history with deleterious mutations. Eighty-five unrelated patients participated. Comprehensive sequencing was performed for MLH1 and MSH2, including all coding regions, splice-site junctions and promoter regions. Of the 29 different mutations found, 11 were deleterious, of which 10 were in MLH1 and 1 in MSH2. Three recurring MLH1 deleterious mutations were found in two unrelated Chinese patients each, and haplotype analysis suggested common ancestral origin for the recurring mutations and possible founder effect. Families with clinical diagnosis of HNPCC (i.e. family history which fulfills the Amsterdam I/II criteria) was the strongest predictor for finding a deleterious mutation, and stomach cancer was the most commonly reported extra-colonic cancer in families found with a deleterious MLH1 or MSH2 mutation. The observation of recurring deleterious MLH1 mutations in our study suggests possible founder effect and may have implications on genetic testing in Asia.

Indexed as

Sequence DeletionAdaptor Proteins, Signal TransducingAsian PeopleColorectal NeoplasmsColorectal Neoplasms, Hereditary NonpolyposisDual Specificity Phosphatase 6FemaleHumansMaleMutationMutL Protein Homolog 1Nuclear ProteinsSecondary PreventionSingaporeAdaptor Proteins, Signal TransducingDual Specificity Phosphatase 6MLH1 protein, humanMutL Protein Homolog 1Nuclear Proteins

Identifiers

PMID18726168
OpenAlexW2037301253

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.